000			02043 a2200565 4500
005			20250516115018.0
264		0	_c20130509
008			201305s 0 0 eng d
022			_a1873-7544
024	7		_a10.1016/j.neuroscience.2012.09.079 _2doi
040			_aNLM _beng _cNLM
100	1		_aNakagawa, T
245	0	0	_aYokukansan inhibits morphine tolerance and physical dependence in mice: the role of α₂A-adrenoceptor. _h[electronic resource]
260			_bNeuroscience _cDec 2012
300			_a336-49 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic Agents _xpharmacology
650	0	4	_aAdrenergic alpha-Antagonists _xpharmacokinetics
650	0	4	_aAdrenergic beta-Antagonists _xpharmacology
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aBehavior, Addictive _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Tolerance
650	0	4	_aDrugs, Chinese Herbal _xtherapeutic use
650	0	4	_aGuanosine 5'-O-(3-Thiotriphosphate) _xpharmacokinetics
650	0	4	_aGuanosine Diphosphate _xpharmacology
650	0	4	_aIsotopes _xpharmacokinetics
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMorphine Dependence _xdrug therapy
650	0	4	_aNorepinephrine Plasma Membrane Transport Proteins _xmetabolism
650	0	4	_aPain Threshold _xdrug effects
650	0	4	_aPropranolol _xpharmacology
650	0	4	_aProtein Binding _xdrug effects
650	0	4	_aRadioligand Assay
650	0	4	_aReceptors, Adrenergic, alpha-2 _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTropanes _xpharmacokinetics
700	1		_aNagayasu, K
700	1		_aNishitani, N
700	1		_aShirakawa, H
700	1		_aSekiguchi, K
700	1		_aIkarashi, Y
700	1		_aKase, Y
700	1		_aKaneko, S
773	0		_tNeuroscience _gvol. 227 _gp. 336-49
856	4	0	_uhttps://doi.org/10.1016/j.neuroscience.2012.09.079 _zAvailable from publisher's website
999			_c22186920 _d22186920